Demo data. These are fictitious sample companies used to preview GroWiser. The figures are not real and are not investment information.
Malabar Remedies Ltd
NSE: MALABARREMBSE: 540987Pharma Formulations
₹3,154.80
▲ 59.35 (+1.92%)
Cash Flow
- FY22: 1,917
- FY23: 3,350
- FY24: 3,261
- FY25: 3,720
- FY26: 4,404
- FY22: -2,206
- FY23: -1,446
- FY24: -3,091
- FY25: -2,502
- FY26: -2,992
- FY22: -720
- FY23: 156
- FY24: -805
- FY25: -858
- FY26: -1,925
| ₹ Cr | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operating activity | 1,917 | 3,350 | 3,261 | 3,720 | 4,404 |
| Capital expenditure | -2,206 | -1,446 | -3,091 | -2,502 | -2,992 |
| Cash from investing activity | -2,353 | -1,699 | -3,202 | -2,767 | -3,290 |
| Cash from financing activity | -284 | -1,496 | -864 | -1,811 | -3,039 |
| Net cash flow | -720 | 156 | -805 | -858 | -1,925 |
Figures in ₹ Cr unless marked per share (₹). Consolidated.
Showing 5 of 10 periods. Premium unlocks the full 10-year history. See Premium